We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Estimation of patient knowledge and medication preference on rheumatic and musculoskeletal diseases in the United Arab Emirates: Single center study at Cleveland Clinic Abu Dhabi.
- Authors
Ha-Neul Yu; Namas, Rajaie; Memisoglu, Lara N.; Lantajo, Bianca; Joy, Annie; Ballan, Manal; Ghani, Noor Abdul; Hegazin, Safa; Elarabi, Mohamed
- Abstract
Background: Knowledge is a vital element in treating patients with rheumatic and musculoskeletal diseases (RMD) which allows the ability to cope with the physical, psychological and social problems associated with the disease burden. In addition, it is essential to the promotion of preference, adherence, compliance, and safety in relation to complex treatment regimes. The aim of the study is to assess the patient awareness on RMD's and estimate the preference in regards to immunosuppressive therapies in the United Arab Emirates (UAE) population who are attending Cleveland Clinic Abu Dhabi. Materials and methods: The study included 2 arms, patients with an established diagnosis of RMD and the patients who were referred to the rheumatology clinic to be screened for an underlying RMD. A self-made questionnaire in 2 languages (English and Arabic) which comprised of 10 questions divided into 2 sets: i) Knowledge on RMDs (gender, level of education, duration of disease, effect on pregnancy, are autoimmune disease curable, and duration patients with the autoimmune disease receive immunosuppressive therapies); ii) Medication preference (oral versus [vs.]. subcutaneous vs. intravenous, daily vs. weekly vs. monthly). Descriptive statistics were used to calculate all participants' responses. Student t-test for quantitative data and the chi-squared test for qualitative data. p<0.05 was considered significant. Results: A total of 455 patients, of which 303 patients had established diagnosis of a RMD (dRMD) and 152 patients screened for underlying rheumatic disease (sRMD), were studied. About 76.7% were females (dRMD: 80.9%; sRMD: 68.4%; p=0.003). Mean age was 43.3±0.7 (dRMD: 41.0±0.8; sRMD: 47.7±1.2; p=0.004). Majority of patients had either College/University/Bachelor's degree (dRMD: 47.9%; sRMD:54.6%), secondary school (dRMD:18.8%; sRMD:15.1%), and Illiterate (dRMD:6.3%; sRMD:12.5%). The most common rheumatic disease was rheumatoid arthritis (37.3%) followed by SLE (32.7%). There were 63.3% answered that RMDs is a curable disease (dRMD: 64.7%; sRMD:69.7%; p=0.28), 56% answered that RMD affect pregnancy or getting pregnant (dRMD: 53.8%; sRMD:60.5%; p=0.17), 7.7% answered the disease is communicable (dRMD: 6.9%; sRMD:9.2%; p=0.39). 49.9% answered that the disease is lifelong, 20.4%( less than one year), 14.5 (1-2 years) and 15.2% (3-5 years). Patients preferred oral medication (74.9%) over subcutaneous injection (11.6%) or intravenous (13.4%) with the highest preference for the monthly medication (42.9%) followed by daily (32.5%) and weekly (24.6%). The majority of patients involved in the study were educated however they have full awareness about RMDs. There were no differences in understanding RMDs between patients with established rheumatic diseases or patients who were screened. Different education levels had significant differences in responses about whether rheumatic autoimmune diseases can be cured and the duration of treatment in patients with established rheumatic autoimmune diseases. Conclusion: These findings highlight the need for raising awareness of rheumatic diseases in our community to promote better understanding and adherence to the treatment regimens in the United Arab Emirates
- Subjects
ABU Dhabi (United Arab Emirates); UNITED Arab Emirates; RHEUMATISM; CLEVELAND Clinic Foundation; MUSCULOSKELETAL system diseases; COMMUNICABLE diseases; PATIENT compliance; RHEUMATOID arthritis; AUTOIMMUNE diseases
- Publication
Saudi Medical Journal, 2022, Vol 43, Issue 6, p642
- ISSN
0379-5284
- Publication type
Article